GL1X · GenesisL1 explorer

UniProt P21589

5'-nucleotidase (P21589)

5'-nucleotidase (UniProt P21589), EC 3.1.3.5: 69 experimental structures and 1 predicted model on GenesisL1, 33 ligands bound, 117 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.

UniProt
P21589
Protein
5'-nucleotidase
EC
3.1.3.5
Experimental structures
69
Predicted models
1
Ligands
33
Pockets
117 · 22 records with a druggable one

Structures

70 records of P21589 in the MolNFT archive: 69 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
4H1SCrystal Structure of a Truncated Soluble form of Human CD73 with Ecto-5'-Nucleotidase activityx-ray diffractionA, B——
4H1SCrystal structure of a truncated soluble form of human CD73 with ecto- 5'-nucleotidase activityx-ray diffractionA, B——
4H1YHuman ecto-5'-nucleotidase (CD73): crystal form II (open) in complex with PSB11552x-ray diffractionP——
4H1YHuman ecto-5'-nucleotidase (CD73): crystal form II (open) in complex with PSB11552x-ray diffractionP——
4H2BHuman ecto-5'-nucleotidase (CD73): crystal form II (open) in complex with Baicalinx-ray diffractionA——
4H2BHuman ecto-5'-nucleotidase (CD73): crystal form II (open) in complex with baicalinx-ray diffractionA——
4H2FHuman ecto-5'-nucleotidase (CD73): crystal form I (open) in complex with adenosinex-ray diffractionA——
4H2FHuman ecto-5'-nucleotidase (CD73): crystal form I (open) in complex with adenosinex-ray diffractionA——
4H2GHuman ecto-5'-nucleotidase (CD73): crystal form II (open) in complex with adenosinex-ray diffractionA——
4H2GHuman ecto-5'-nucleotidase (CD73): crystal form II (open) in complex with adenosinex-ray diffractionA——
4H2IHuman ecto-5'-nucleotidase (CD73): crystal form III (closed) in complex with AMPCPx-ray diffractionA——
4H2IHuman ecto-5'-nucleotidase (CD73): crystal form III (closed) in complex with ampcpx-ray diffractionA——
6HXWstructure of human CD73 in complex with antibody IPH53x-ray diffractionA, BNAG, ZN—
6HXWStructure of human CD73 in complex with antibody IPH53x-ray diffractionA, BNAG, ZN—
6S7FHuman CD73 (5'-nucleotidase) in complex with PSB12379 (an AOPCP derivative) in the closed statex-ray diffractionAZN, CA, KYK3 (best 0.74)
6S7FHuman CD73 (5'-nucleotidase) in complex with PSB12379 (an aopcp derivative) in the closed statex-ray diffractionAZN, CA, KYK—
6S7HHuman CD73 (5'-nucleotidase) in complex with PSB12489 (an AOPCP derivative) in the closed statex-ray diffractionAZN, CA, KYW3 (best 0.75)
6S7HHuman CD73 (5'-nucleotidase) in complex with PSB12489 (an aopcp derivative) in the closed statex-ray diffractionAZN, CA, KYW—
6TVEUnliganded human CD73 (5'-nucleotidase) in the open statex-ray diffractionPCA, ZN4 (best 0.64)
6TVEUnliganded human CD73 (5'-nucleotidase) in the open statex-ray diffractionPCA, ZN—
6TVXHuman CD73 (ecto 5'-nucleotidase) in complex with PSB12676 (an AOPCP derivative, compound 9 in…x-ray diffractionAZN, NYW4 (best 0.74)
6TVXHuman CD73 (ecto 5'-nucleotidase) in complex with PSB12676 (an aopcp derivative, compound 9 in…x-ray diffractionAZN, NYW—
6TW0Human CD73 (ecto 5'-nucleotidase) in complex with PSB12690 (an AOPCP derivative, compound 10 in…x-ray diffractionAZN, NYZ4 (best 0.74)
6TW0Human CD73 (ecto 5'-nucleotidase) in complex with PSB12690 (an aopcp derivative, compound 10 in…x-ray diffractionAZN, NYZ—
6TWAHuman CD73 (ecto 5'-nucleotidase) in complex with PSB12646 (an AOPCP derivative, compound 20 in…x-ray diffractionAZN, O02, CA4 (best 0.74)
6TWAHuman CD73 (ecto 5'-nucleotidase) in complex with PSB12646 (an aopcp derivative, compound 20 in…x-ray diffractionAZN, O02, CA—
6TWFHuman CD73 (ecto 5'-nucleotidase) in complex with PSB12604 (an aopcp derivative, compound 21 in…x-ray diffractionAZN, CA, O05—
6XUEHuman Ecto-5'-nucleotidase (CD73) in complex with A2396 (compound 74 in publication) in the closed…x-ray diffractionA, BZN, CA, PO4, O1H—
6XUEHuman ecto-5'-nucleotidase (CD73) in complex with A2396 (compound 74 in publication) in the closed…x-ray diffractionA, BZN, CA, PO4, O1H—
6XUGHuman ecto-5'-nucleotidase (CD73) in complex with A2410 (compound 53 in publication) in the closed…x-ray diffractionA, BZN, CA, PO4, O1Q—
6XUQHuman Ecto-5'-nucleotidase (CD73) in complex with A1618 (compound 1b in publication) in the closed…x-ray diffractionAZN, CA, O1T5 (best 0.75)
6XUQHuman ecto-5'-nucleotidase (CD73) in complex with A1618 (compound 1B in publication) in the closed…x-ray diffractionAZN, CA, O1T—
6YE1Human Ecto-5'-nucleotidase (CD73) in complex with the AMPCP derivative A894 (compound 2n in…x-ray diffractionA, BZN, OO28 (best 0.76)
6YE1Human ecto-5'-nucleotidase (CD73) in complex with the ampcp derivative A894 (compound 2N in…x-ray diffractionA, BZN, OO2—
6YE2Human Ecto-5'-nucleotidase (CD73) in complex with the AMPCP derivative A1202 (compound 4a in…x-ray diffractionA, BZN, OO5, CA9 (best 0.76)
6YE2Human ecto-5'-nucleotidase (CD73) in complex with the ampcp derivative A1202 (compound 4A in…x-ray diffractionA, BZN, OO5, CA—
6Z9BHuman Ecto-5'-nucleotidase (CD73) in complex with AOPCP derivative A830 (compound 16 in…x-ray diffractionAZN, CA, QCQ5 (best 0.76)
6Z9BHuman ecto-5'-nucleotidase (CD73) in complex with aopcp derivative A830 (compound 16 in…x-ray diffractionAZN, CA, QCQ—
6Z9DHuman ecto-5'-nucleotidase (CD73) in complex with aopcp derivative AB680 (compound 55 in…x-ray diffractionAZN, CA, QDH—
7BBJCD73 in complex with the humanized antagonistic antibody MAB19x-ray diffractionA, BZN, MG—
7JV8Human CD73 (ecto 5'-nucleotidase) in complex with compound 35x-ray diffractionA, B, C, DZN, CA, VPD18 (best 0.85)
7JV8Human CD73 (ecto 5'-nucleotidase) in complex with compound 35x-ray diffractionA, B, C, DZN, CA, VPD—
7JV9Human CD73 (ecto 5'-nucleotidase) in complex with compound 12x-ray diffractionA, BZN, CA, NAG, VPG, PO47 (best 0.85)
7JV9Human CD73 (ecto 5'-nucleotidase) in complex with compound 12x-ray diffractionA, BZN, CA, NAG, VPG, PO4—
7P9NCrystal structure of CD73 in complex with AMP in the open formx-ray diffractionAZN, CA, AMP—
7P9NCrystal structure of CD73 in complex with AMP in the open formx-ray diffractionAZN, CA, AMP—
7P9RCrystal structure of CD73 in complex with GMP in the open formx-ray diffractionAZN, CA, G4 (best 0.66)
7P9RCrystal structure of CD73 in complex with gmp in the open formx-ray diffractionAZN, CA, G—
7P9TCrystal structure of CD73 in complex with dCMP in the open formx-ray diffractionAZN, CA, DCM4 (best 0.74)
7P9TCrystal structure of CD73 in complex with dcmp in the open formx-ray diffractionAZN, CA, DCM—
7PA4Crystal structure of CD73 in complex with CMP in the open formx-ray diffractionAZN, CA, CL, C6 (best 0.66)
7PA4Crystal structure of CD73 in complex with cmp in the open formx-ray diffractionAZN, CA, CL, C—
7PB5Crystal structure of CD73 in complex with UMP in the open formx-ray diffractionAZN, CA, U5 (best 0.66)
7PB5Crystal structure of CD73 in complex with ump in the open formx-ray diffractionAZN, CA, U—
7PBACrystal structure of CD73 in complex with IMP in the open formx-ray diffractionAZN, CA, IMP4 (best 0.66)
7PBACrystal structure of CD73 in complex with imp in the open formx-ray diffractionAZN, CA, IMP—
7PBBCrystal structure of CD73 in complex with caffeine in the open formx-ray diffractionAZN, CA, CFF—
7PBYCrystal structure of CD73 in complex with 4-nitrocatechol in the open formx-ray diffractionAZN, CA, 4NC3 (best 0.65)
7PBYCrystal structure of CD73 in complex with 4-nitrocatechol in the open formx-ray diffractionAZN, CA, 4NC—
7PCPCrystal structure of CD73 in complex with 5-iodouracil in the open formx-ray diffractionAZN, CA, IUR6 (best 0.67)

10 records more on the page itself.

Ligands

  • ZN · Zinc ion · in 57 records
  • CA · Calcium ion · in 46 records
  • PO4 · Phosphate ion · in 5 records
  • BW0 · [[(2~{R},3~{S},4~{R},5~{R})-5-[(4~{E})-4-[(4-methoxycarbonylphenyl)methoxyimino]-3-methyl-2-oxidanylidene-pyrimidin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]methylphosphonic acid · in 4 records
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · in 4 records
  • 4NC · 4-nitrocatechol · in 2 records
  • AMP · Adenosine monophosphate · in 2 records
  • BOI · [[(2~{R},3~{S},4~{R},5~{R})-5-[(4~{E})-4-[(4-chlorophenyl)methoxyimino]-3-methyl-2-oxidanylidene-pyrimidin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]methylphosphonic acid · in 2 records
  • C · Cytidine-5'-monophosphate · in 2 records
  • CL · Chloride ion · in 2 records
  • DCM · 2'-deoxycytidine-5'-monophosphate · in 2 records
  • G · Guanosine-5'-monophosphate · in 2 records
  • IMP · Inosinic acid · in 2 records
  • IUR · 5-iodouracil · in 2 records
  • KYK · N6-benzyl-(alpha,beta)-methylene-ADP · in 2 records
  • KYW · (N6,N6)-methyl,benzyl-C2-chloro-(alpha,beta)-methylene-ADP · in 2 records
  • NYW · [[(2~{R},3~{S},4~{R},5~{R})-5-[2,6-bis(azanyl)purin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]methylphosphonic acid · in 2 records
  • NYZ · [[(2~{R},3~{S},4~{R},5~{R})-5-(6-azanyl-2-oxidanylidene-3~{H}-purin-9-yl)-3,4-bis(oxidanyl) oxolan-2-yl]methoxy-oxidanyl-phosphoryl]methylphosphonic acid · in 2 records
  • O02 · [[(2~{R},3~{S},4~{R},5~{R})-5-(6-azanyl-2-diazanyl-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]methylphosphonic acid · in 2 records
  • O1H · 4-[[5-[7-chloranyl-3-(1~{H}-indazol-6-yl)benzotriazol-5-yl]pyrazol-1-yl]methyl]benzenecarbonitrile · in 2 records
  • O1T · [[(2~{R},3~{S},4~{R},5~{R})-5-[6-chloranyl-4-[[(1~{S})-1-(4-fluorophenyl)ethyl]amino]pyrazolo[3,4-b]pyridin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]methylphosphonic acid · in 2 records
  • OO2 · [(2~{R},3~{S},4~{R},5~{R})-5-[2-chloranyl-6-(cyclopentylamino)purin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxymethylphosphonic acid · in 2 records
  • OO5 · [(2~{R},3~{S},4~{R},5~{R})-5-[6-chloranyl-4-(cyclopentylamino)pyrazolo[3,4-d]pyrimidin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxymethylphosphonic acid · in 2 records
  • QCQ · [[(2~{R},3~{R},4~{S},5~{R})-5-[2-chloranyl-6-[(phenylmethyl)amino]purin-9-yl]-4-fluoranyl-3-oxidanyl-oxolan-2-yl]methoxy-oxidanyl-phosphoryl]methylphosphonic acid · in 2 records
  • RBF · Riboflavin · in 2 records
  • U · Uridine-5'-monophosphate · in 2 records
  • VPD · 6-chloro-N-cyclopentyl-1-{5-O-[(2R)-1-hydroxy-3-methoxy-2-phosphonopropan-2-yl]-beta-D-ribofuranosyl}-1H-pyrazolo[3,4-d]pyrimidin-4-amine · in 2 records
  • VPG · 6-chloro-N-[(2-chlorophenyl)methyl]-1-[5-O-(phosphonomethyl)-beta-D-ribofuranosyl]-1H-pyrazolo[3, 4-d]pyrimidin-4-amine · in 2 records
  • CFF · Caffeine · in 1 record
  • MG · Magnesium ion · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.